MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2013.

NCT00107432 | COMPLETED | PHASE2
44 participants

Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-05
Start Date:
2004-10-31
Completion:
2007-06-30
Conditions
  • Epithelial Mesothelioma
  • Recurrent Malignant Mesothelioma
  • Sarcomatous Mesothelioma
  • Stage IA Malignant Mesothelioma
  • Stage IB Malignant Mesothelioma
  • Stage II Malignant Mesothelioma
  • Stage III Malignant Mesothelioma
  • Stage IV Malignant Mesothelioma
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00101270 | COMPLETED | PHASE1
24 participants

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-05
Start Date:
2005-03-31
Completion:
2007-09-30
Conditions
  • Childhood Burkitt Lymphoma
  • Childhood Central Nervous System Germ Cell Tumor
  • Childhood Diffuse Large Cell Lymphoma
  • Childhood Grade III Lymphomatoid Granulomatosis
  • Childhood Immunoblastic Large Cell Lymphoma
  • Recurrent Childhood Brain Stem Glioma
  • Recurrent Childhood Cerebellar Astrocytoma
  • Recurrent Childhood Cerebral Astrocytoma
  • Recurrent Childhood Ependymoma
  • Recurrent Childhood Grade III Lymphomatoid Granulomatosis
  • Recurrent Childhood Large Cell Lymphoma
  • Recurrent Childhood Liver Cancer
  • Recurrent Childhood Lymphoblastic Lymphoma
  • Recurrent Childhood Malignant Germ Cell Tumor
  • Recurrent Childhood Medulloblastoma
  • Recurrent Childhood Rhabdomyosarcoma
  • Recurrent Childhood Small Noncleaved Cell Lymphoma
  • Recurrent Childhood Soft Tissue Sarcoma
  • Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
  • Recurrent Childhood Visual Pathway Glioma
  • Recurrent Colon Cancer
  • Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Recurrent Melanoma
  • Recurrent Nasopharyngeal Cancer
  • Recurrent Neuroblastoma
  • Recurrent Osteosarcoma
  • Recurrent Wilms Tumor and Other Childhood Kidney Tumors
  • Recurrent/Refractory Childhood Hodgkin Lymphoma
  • Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
  • DRUG
No Results Yet
NCT00091182 | COMPLETED | PHASE2
180 participants

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-05
Start Date:
2004-10-31
Completion:
2006-02-28
Conditions
  • Childhood Central Nervous System Germ Cell Tumor
  • Childhood Extragonadal Germ Cell Tumor
  • Childhood Hepatoblastoma
  • Childhood Hepatocellular Carcinoma
  • Childhood High-grade Cerebral Astrocytoma
  • Childhood Low-grade Cerebral Astrocytoma
  • Childhood Malignant Ovarian Germ Cell Tumor
  • Childhood Malignant Testicular Germ Cell Tumor
  • Childhood Teratoma
  • Recurrent Adrenocortical Carcinoma
  • Recurrent Childhood Brain Stem Glioma
  • Recurrent Childhood Cerebellar Astrocytoma
  • Recurrent Childhood Cerebral Astrocytoma
  • Recurrent Childhood Ependymoma
  • Recurrent Childhood Liver Cancer
  • Recurrent Childhood Malignant Germ Cell Tumor
  • Recurrent Childhood Rhabdomyosarcoma
  • Recurrent Childhood Soft Tissue Sarcoma
  • Recurrent Childhood Visual Pathway and Hypothalamic Glioma
  • Recurrent Colon Cancer
  • Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Recurrent Nasopharyngeal Cancer
  • Recurrent Neuroblastoma
  • Recurrent Osteosarcoma
  • Recurrent Rectal Cancer
  • Recurrent Renal Cell Cancer
Interventions
  • DRUG
No Results Yet
NCT00079404 | COMPLETED | PHASE1
36 participants

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-05
Start Date:
2004-03-31
Completion:
2006-05-31
Conditions
  • Acute Undifferentiated Leukemia
  • Recurrent Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
  • DRUG
No Results Yet
NCT00077467 | COMPLETED | PHASE1
36 participants

Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-05
Start Date:
2004-01-31
Completion:
2006-03-31
Conditions
  • Blastic Phase Chronic Myelogenous Leukemia
  • Childhood Acute Promyelocytic Leukemia (M3)
  • Recurrent Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood Acute Myeloid Leukemia
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00077454 | COMPLETED | PHASE1
95 participants

Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-05
Start Date:
2004-02-29
Completion:
2007-09-30
Conditions
  • Previously Treated Childhood Rhabdomyosarcoma
  • Recurrent Childhood Brain Tumor
  • Recurrent Childhood Cerebellar Astrocytoma
  • Recurrent Childhood Cerebral Astrocytoma
  • Recurrent Childhood Ependymoma
  • Recurrent Childhood Malignant Germ Cell Tumor
  • Recurrent Childhood Medulloblastoma
  • Recurrent Childhood Rhabdomyosarcoma
  • Recurrent Childhood Soft Tissue Sarcoma
  • Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
  • Recurrent Neuroblastoma
  • Recurrent Osteosarcoma
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00072150 | COMPLETED | PHASE2
40 participants

Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-05
Start Date:
2003-10-31
Completion:
2006-03-31
Conditions
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • Recurrent Bladder Cancer
  • Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
  • Recurrent Urethral Cancer
  • Stage III Bladder Cancer
  • Stage III Urethral Cancer
  • Stage IV Bladder Cancer
  • Stage IV Urethral Cancer
  • Transitional Cell Carcinoma of the Bladder
  • Ureter Cancer
Interventions
  • DRUG
No Results Yet
NCT00042900 | COMPLETED | PHASE1

Pyroxamide in Treating Patients With Advanced Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-05
Start Date:
2002-04-30
Completion:
2002-09-30
Conditions
  • Chronic Myeloproliferative Disorders
  • Leukemia
  • Lymphoma
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Myelodysplastic Syndromes
  • Precancerous Condition
  • Small Intestine Cancer
  • Unspecified Adult Solid Tumor, Protocol Specific
Interventions
  • DRUG
No Results Yet
NCT00040794 | COMPLETED | PHASE2
144 participants

Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2013-06-05
Start Date:
2002-05-31
Completion:
2006-03-31
Conditions
  • Adenocarcinoma of the Lung
  • Adenosquamous Cell Lung Cancer
  • Bronchoalveolar Cell Lung Cancer
  • Large Cell Lung Cancer
  • Squamous Cell Lung Cancer
  • Stage IIIA Non-small Cell Lung Cancer
  • Stage IIIB Non-small Cell Lung Cancer
Interventions
  • DRUG
  • RADIATION
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page